Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs

被引：0
|
作者：
Vitale, Candida [1 ,2 ]
Salvetti, Chiara [1 ,2 ]
Griggio, Valentina [1 ]
Scamuffa, Maria Cristina [3 ]
Zamprogna, Giulia [4 ]
Visentin, Andrea [5 ]
Cassin, Ramona [6 ]
Laurenti, Luca [7 ]
Murru, Roberta [8 ]
Rivela, Paolo [9 ]
Marchetti, Monia [10 ]
Gentile, Massimo [11 ,12 ]
Pennese, Elsa [13 ]
Reda, Gianluigi [6 ]
Trentin, Livio [5 ]
Tedeschi, Alessandra [4 ]
Mauro, Francesca Romana [3 ]
Foa, Robin [3 ]
Boccadoro, Mario [1 ,2 ]
Coscia, Marta [1 ,2 ]
机构：
[1] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy
[2] AOU Citta Salute Scienza Torino, Div Hematol, Turin, Italy
[3] Sapienza Univ, Dept Translat & Precis Med, Policlin Umberto, Hematol, Rome, Italy
[4] ASST Grande Osped Metropolitano Niguarda, Milan, Italy
[5] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Padua, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UOC Ematol, Milan, Italy
[7] Fdn Policlin Univ Agostino Gemelli IRCSS, Inst Hematol, Rome, Italy
[8] Osped Businco, Hematol & Stem Cell Transplantat Unit, Cagliari, Italy
[9] AO SS Antonio & Biagio & Cesare Arrigo, Div Hematol, Alessandria, Italy
[10] Osped Cardinal Massaia, Oncol Unit, Hematol Day Serv, Asti, Italy
[11] AO Cosenza, Hematol Unit, Cosenza, Italy
[12] AO Cosenza, Biotechnol Res Unit, Cosenza, Italy
[13] ASL Pescara, UOSD Terapia Intensiva Ematolog, Pescara, Italy
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3044
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
    Eugene Nikitin
    Maria Kislova
    Dmitry Morozov
    Vera Belyakova
    Anna Suvorova
    Julia Sveshnikova
    Galina Vyscub
    Irina Matveeva
    Maria Shirokova
    Anna Shipaeva
    Tatyana Klitochenko
    Polina Makarovskaya
    Elena Dmitrieva
    Bella Biderman
    Andrei Sudarikov
    Tatyana Obukhova
    Olga Samoilova
    Kamil Kaplanov
    Tatyana Konstantinova
    Olga Mayorova
    Irina Poddubnaya
    Vadim Ptushkin
    Leukemia, 2023, 37 : 1464 - 1473
  • [22] Ibrutinib in patients with autoimmune cytopenias and previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) from the phase 3 RESONATETM study
    Montillo, Marco
    O'Brien, Susan
    Tedeschi, Alessandra
    Byrd, John
    Dearden, Claire
    Gill, Devinder
    Brown, Jennifer
    Barrientos, Jacqueline
    Mulligan, Stephen
    Furman, Richard
    Cymbalista, Florence
    Plascencia, Clara
    Chang, Stephen
    Hsu, Emily
    James, Danelle
    Hillmen, Peter
    LEUKEMIA & LYMPHOMA, 2015, 56 : 150 - 151
  • [23] Safety Findings of Dosing Gene Therapy Vectors in NHP With Pre-existing or Treatment-Emergent Anti-capsid Antibodies
    Chandra, Sundeep
    Long, Brian R.
    Fonck, Carlos
    Melton, Andrew C.
    Arens, Jeremy
    Woloszynek, Jill
    O'Neill, Charles A.
    TOXICOLOGIC PATHOLOGY, 2023, 51 (05) : 246 - 256
  • [24] Successful kidney transplantation in a patient with pre-existing chronic myeloid leukemia treated with imatinib
    Thiem, Ursula
    Buxhofer-Ausch, Veronika
    Kranewitter, Wolfgang
    Webersinke, Gerald
    Enkner, Wolfgang
    Cejka, Daniel
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (01) : 405 - 409
  • [25] Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with target-ed drugs: pooled analysis of clinical trials from the German CLL Study Group (GCLLSG)
    Boccellato, Elia
    Giza, Adam
    Robrecht, Sandra
    Cramer, Paula
    von Tresckow, Julia
    Al-Sawaf, Othman
    Furstenau, Moritz
    Tausch, Eugen
    Stilgenbauer, Stephan
    Fischer, Kirsten
    Eichhorst, Barbara
    Vitale, Candida
    Coscia, Marta
    Hallek, Michael
    Langerbeins, Petra
    LEUKEMIA & LYMPHOMA, 2023, 64 : S4 - S5
  • [26] Safety of Immune Checkpoint Inhibitors in Patients Treated for Cancer with Pre-existing Autoimmune Diseases
    Kaur, Aneet
    Swami, Umang
    Fatima, Munazza
    Ginn, Meredith
    Stein, Jill
    Gao, Yubo
    Zakharia, Yousef
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
    Fresa, Alberto
    Autore, Francesco
    Galli, Eugenio
    Tomasso, Annamaria
    Stirparo, Luca
    Innocenti, Idanna
    Laurenti, Luca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [28] Bendamustine is a safe and effective therapy in heavily pre-treated patients with B-cell-chronic lymphocytic leukaemia (B-CLL), even with pre-existing autoimmune phenomena.
    Schulte, K
    Aivado, M
    Neise, M
    Strupp, C
    Losem, C
    Hentze, L
    Haas, R
    BLOOD, 2001, 98 (11) : 292B - 292B
  • [29] Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre
    Hampel, Paul J.
    Larson, Melissa C.
    Kabat, Brian
    Call, Timothy G.
    Ding, Wei
    Kenderian, Saad S.
    Bowen, Deborah
    Boysen, Justin
    Schwager, Susan M.
    Leis, Jose F.
    Chanan-Khan, Asher A.
    Muchtar, Eli
    Hanson, Curtis A.
    Slager, Susan L.
    Kay, Neil E.
    Chaffee, Kari G.
    Shanafelt, Tait D.
    Parikh, Sameer A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 421 - 427
  • [30] Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
    Visco, Carlo
    Cortelezzi, Agostino
    Moretta, Francesca
    Falisi, Erika
    Maura, Francesco
    Finotto, Silvia
    Barcellini, Wilma
    Ambrosetti, Achille
    Neri, Antonino
    Ruggeri, Marco
    Rodeghiero, Francesco
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1261 - 1265
12345